PTI-2

PTI-2 (SGT-49) is an indole-based synthetic cannabinoid. It is one of few synthetic cannabinoids containing a thiazole group and is closely related to PTI-1. These compounds may be viewed as simplified analogues of indole-3-heterocycle compounds originally developed by Organon and subsequently further researched by Merck.
Wikipedia contributors, "PTI-2", Wikipedia, revision 1330451166, retrieved 20 November 2026, source, CC BY-SA 4.0.